Phototherapy for newborn jaundice
A treatment for high bilirubin in newborn jaundice. A 2021 review describes phototherapy as the treatment of first choice for jaundice in newborns, and also says some studies link it to harms. When to start it is set by guidelines that this atlas lists as references only.
Also called Light treatment for jaundice
- Intervention
- In this atlas
Overview
Technical summary
Evidence recorded here is one narrative review (Experimental and Therapeutic Medicine, 2021; cite only, CC BY-NC-ND). It gives no effect size, threshold or schedule. The phototherapy thresholds of the 2022 US paediatrics guideline are not recorded, because that publisher’s content is identity-only in this atlas.
About this intervention
- Type
- Procedure
- Mechanism
- Not reported
Claims and evidence
Context Neonates with jaundice (narrative review of phototherapy)
- Recipient
- Newborn
- Population
- Neonates with jaundice and high serum bilirubin, as discussed in a narrative review. The abstract sets no gestational age or setting.
- Care setting
- Not stated in the source.
- Geography
- Not stated in the source.
- Life stage
- Neonatal period
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable: a review.
Eligibility: 1 inclusion criterion; exclusion criteria not stated
- Included
- Neonates with jaundice
- Excluded
- None stated
A 2021 narrative review describes phototherapy as the treatment of first choice for jaundice in newborns, and says it lowers a high level of unbound bilirubin and limits that bilirubin's toxic effect on nerves. The review also says some studies link phototherapy to harms in the short and long term, ranging from red blood cell breakdown to allergic disease, and it calls for an agreed, standard way of giving it.
Applies to Newborn- Neonates with jaundice and high serum bilirubin, as discussed in a narrative review. The abstract sets no gestational age or setting.
- Not stated in the source.
- Not stated in the source.
- Neonatal period
- Gestational age Not reported
- Postnatal age Not reported
- Certainty method
- Not assessed
- Limitations
- A narrative review, not a trial, so it gives no effect size, threshold or schedule. It sets no population or setting. The source licence is CC BY-NC-ND and this atlas treats the source as cite only, so the statement is in the atlas's own words. Only the abstract was read. When to start phototherapy is set by guidelines that this atlas lists as references only.
- Last checked
- Not recorded
- Next evidence check due
- Not scheduled
Sources and citations (3)
-
Supports Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
- Locator
- Abstract, sentences 1 and 2
- How it applies
- The role of phototherapy and the adverse reactions suggested by some studies.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
7b5449c750bd54f93d572c6174f9fd456374b98513c9880f1e66961a76666a4f- Reuse basis
- PMC Open Access subset article, but its licence (https://creativecommons.org/licenses/by-nc-nd/4.0/) is not one this tool treats as redistributable (CC0, CC BY, CC BY-SA, CC BY-ND). Only the hash of the bytes is kept. Short quotations under 25 words.
-
Background Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
- Locator
- Abstract, sentence 4
- How it applies
- The review's aim.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
7b5449c750bd54f93d572c6174f9fd456374b98513c9880f1e66961a76666a4f- Reuse basis
- PMC Open Access subset article, but its licence (https://creativecommons.org/licenses/by-nc-nd/4.0/) is not one this tool treats as redistributable (CC0, CC BY, CC BY-SA, CC BY-ND). Only the hash of the bytes is kept. Short quotations under 25 words.
-
Background Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
- Locator
- article-meta, pub-date (epub), year
- How it applies
- Year of the review.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Snapshot hash
7b5449c750bd54f93d572c6174f9fd456374b98513c9880f1e66961a76666a4f- Reuse basis
- PMC Open Access subset article, but its licence (https://creativecommons.org/licenses/by-nc-nd/4.0/) is not one this tool treats as redistributable (CC0, CC BY, CC BY-SA, CC BY-ND). Only the hash of the bytes is kept. Short quotations under 25 words.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Review: treatment of first choice for newborn jaundice: Newborn jaundice (hyperbilirubinaemia)
Applies to Newborn- Neonates with jaundice and high serum bilirubin, as discussed in a narrative review. The abstract sets no gestational age or setting.
- Not stated in the source.
- Not stated in the source.
- Neonatal period
- Gestational age Not reported
- Postnatal age Not reported
A 2021 narrative review describes phototherapy as the treatment of first choice for jaundice in newborns, and says it lowers a high level of unbound bilirubin and limits that bilirubin's toxic effect on nerves. The review also says some studies link phototherapy to harms in the short and long term, ranging from red blood cell breakdown to allergic disease, and it calls for an agreed, standard way of giving it.Limitations. A narrative review, not a trial, so it gives no effect size, threshold or schedule. It sets no population or setting. The source licence is CC BY-NC-ND and this atlas treats the source as cite only, so the statement is in the atlas's own words. Only the abstract was read. When to start phototherapy is set by guidelines that this atlas lists as references only.
Record details
- Record id
maternal:phototherapy- Content hash
d7b88f850ccb6f0fad6b329aba3c0affcac99e5a34f25e846128b7cacbd9ea09